Scorpion venom: pharmacological analysis and its applications by Chaubey, Mukesh Kumar
ISSN 2449-8955 
European Journal  
of Biological Research Review Article 
 
European Journal of Biological Research 2017; 7 (4): 271-290 
 
Scorpion venom: pharmacological analysis  
and its applications 
 
Mukesh Kumar Chaubey 
  







Scorpions belong to class: Arachnida, order: 
Scorpionida represented now by approximately 
1500 species. These are one of the most ancient 
group of the animals on the earth conserving their 
morphology almost unaltered and are the most 
successful inhabitants of the earth. Scorpions when 
stimulated secrete venom which is a cocktail of 
variable concentration of neurotoxins, cardiotoxins, 
nephrotoxins, hemolytic toxins, phosphodiesterases, 
phospholipases, hyaluronidase, glucosaminoglycans, 
histamine, seratonin, tryptophan and cytokine 
releasers. According to an estimate, frequency of 
deaths caused by scorpion sting is higher in 
comparison to that of caused by snake-bite. Almost 
all of these lethal scorpions except Hemiscorpious 
species belong to scorpion family Buthidae 
comprising 500 species. Scorpion venoms show 
variable reactions in envenomated patients. 
However, closer the phylogenic relationship among 
the scorpions, more similar the immunological 
properties. Furthermore, various constituents of 
venom may act directly or indirectly and 
individually or synergistically to exert their effects. 
Scorpion stings cause a wide range of conditions 
from severe local skin reactions to neurologic, 
respiratory and cardiovascular collapse. Lethal 
members of Buthidae family include Buthus, 
Parabuthus, Mesobuthus, Tityus, Leiurus, Andro-
ctonus and Centruroides. Besides their lethal 
properties, scorpion venoms have some unique 
properties beneficial to mankind. These contain 
anti-insect, antimicrobial and anticancer properties 
and thus, can play a key role in the insect pest 
management programmes, treatment of microbial 
infection and in the treatment of various cancer 
types. 
  
Keywords: Scorpion venom; Envenomation; 





 Scorpion sting is a major health problem in 
under developed tropical countries especially in 
poor communities. According to an estimate, 
frequency of deaths caused by scorpion sting is 
higher in comparison to that of caused by snake-bite 
[1]. Scorpions belong to class: Arachnida, order: 
Scorpionida. Scorpion has flattened and elongated 
body with four pairs of legs, a pair of claws and a 
segmental tail that has a poisonous spike at the end. 
Scorpion varies in size according to age and species 
from 1-20 cm in length. These can be found outside 
their normal territory when they accidentally crawl 
into luggage, boxes, containers or shoes, and are 
transported to home via human unwillingly. These 
are one of the most ancient group of the animals on 
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the earth represented now by approximately 1500 
species conserving their morphology almost 
unaltered [2, 3]. 
 Scorpions are not aggressive and do not hunt 
but wait for its prey. Scorpions being nocturnal in 
habit and capture its prey during night. They hide in 
crevices and burrow during day time to avoid the 
light. Human stinging occurs accidentally when 
scorpions are touched during resting and most of the 
stings occur on hands and feets. Scorpions are well 
equipped with a pair of pincer like pedipalps. Thus, 
peoples question why they need to produce venom 
at the same time. This is because most scorpions are 
opportunistic predators lacking the speed of its prey 
like insects and thus they are not choosy in their 
prey selection. Also obtaining relatively large prey 
like mouse and large beetles is a quite tough task for 
a scorpion. In such condition, pedipalps may prove 
insufficient to manage prey as quickly as possible. 
Thus, venom which is nature’s gift provided to 
scorpions comes into play. A second advantage of 
venom is the presence of enzymes as venom’s 
constituents with diverse activity. These enzymes 
initiate the process of digestion in tissue of the prey 
stung before consumption. Scorpion venom is an 
effective defensive device, which serves to deter and 
incapacitate the opponent. Hissing and aggressive 
defense posture is usually enough to deter most 
animals including human. When deterrence proves 
inadequate scorpions defend itself by injecting 
venom into the body of enemy. Thus, the main 
purpose of production of venom in scorpions is to 
secure food and self-protection. 
 Venom glands, the factory of scorpion’s 
venom are located on the lateral side of tip of sting. 
These are made of different types of tall columnar 
cells. Of these cells, one type produces toxins while 
others produce mucus. Potency of scorpion’s venom 
varies from species to species with some producing 
only a mild flu while other producing death. 
Scorpion stings cause a wide range of conditions 
from severe local skin reactions to neurologic, 
respiratory and cardiovascular collapse.  Scorpion 
venoms exert their action mainly by affecting 
specific functions of the ion channels [4-6]. Among 
well-characterized toxins peptides from venom of 
the scorpion, most of them belong to family 
Buthidae. Buthoid venom has been reported for its 
severe consequences against a wide variety of 
vertebrate and invertebrate organisms and its 
toxicity is attributed to the presence of a large 
variety of basic polypeptides having three to four 
disulfide bridges [4, 7]. Due to heterogeneous 
nature, scorpion venoms show variable reactions in 
envenomated patients. However, closer the phylo-
genic relationship among the scorpions, more 
similar the immunological properties. Furthermore, 
various constituents of venom may act directly or 
indirectly and individually or synergistically to exert 
their effects. In addition, differences in amino          
acid sequences of each toxin accounts for their 
differences in function, pharmacology and immu-
nology. Thus, any alteration in amino acid sequence 
may result in modification of function, pharma-
cology and immunology of toxin. 
 Differences in pathogenecity and level of 
toxicity of scorpion venom are actually due to 
diversity in toxin peptides and differences in amino 
acids in active site region of toxin peptides. This 
leads to diversification in their mode of action in 
different venomous scorpion groups in different 
climatic conditions and finally results into 
ecological adaptation in due course of evolutionary 
journey. Scorpions when stimulated secrete a small 
quantity of transparent venom called prevenom. If 
stimulation continues, cloudy, dense and white 
coloured venom is released subsequently. Prevenom 
contains a concentration of high K+ salt and several 
peptides including some that block K+ channels. 
This prevenom causes significant toxicity and 
scorpions use it as a highly efficacious predator 
deterrent and for immobilizing small prey while 
conserving metabolically expensive venom until a 
certain level of stimuli is reached [8]. That is why 
scorpions are known to be economical in their use 
of venom. 
 Production and storage of venom is an 
expensive metabolic process especially for species 
of extreme ecosystems. Other than antimicrobial 
peptides, all neurotoxins in venom are highly folded 
disulfide bridged molecules [9]. Low yields and 
reduced expression of these highly folded peptides 
in recombinant system indicates unique and  
difficult folding and storage requirement [10]. 
About fifty scorpion species distributed throughout 
the world have been proved lethal to human [11, 
12]. Almost all of these lethal scorpions except 
Hemiscorpius species belong to scorpion family 
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Buthidae comprising 500 species. Lethal members 
of Buthidae family include Buthus, Parabuthus, 
Mesobuthus, Tityus, Leiurus, Androctonus and 
Centruroides. Common scorpions and their distri-
butions are: 
1. Buthus: Mediterranean area 
2. Parabuthus: Southern and Western Africa 
3. Mesobuthus: Asia 
4. Tityus: Central and South America 
5. Leiurus: Northern Africa 
6. Androctonus: Northern Africa to South-East Asia 
7. Cetruroides: South-West USA, Mexico, Central 
America 
8. Heterometrus: Asia 
9. Pandinus: Tropical Africa and Arabian Peninsula. 
 Scorpions mostly occur in temperate and 
tropical habitats of the world. They are well adapted 
to survive in extreme thermal environments, 
sometimes constituting a major portion of the total 
animal biomass in such environments. These are 
considered among the most successful inhabitants  
of the earth [13, 14]. Although numerous factors 
contribute to the success of scorpions, the ability to 
produce and deliver highly toxic venom is an 
important determinant of their success. 
 Scorpion venom is composed of water, salts, 
biogenic amines, peptides and enzymes. Venom of 
several scorpion species has been well characterized 
and various toxin peptides possessing the majority 
of biological activities have been isolated [15]. In 
venom mixture, there are many peptides that are 
specifically active against vertebrates, invertebrates 
or both. Toxin peptides of all these three groups are 
well characterized and includes peptides that target 
all the major ion channels such as Na+, K+, Cl-, Ca++ 
and rynodine sensitive Ca++ channels [15, 16]. 
Potency of venom is mainly due to its ability to 
target multiple types of ion channels simultaneously 
resulting in a massive and recurring depolarization 
of nerve fibres that disables or kills prey or 
predators.  
 Generally scorpion venom possesses variable 
concentration of neurotoxins, cardiotoxins, nephro-
toxins, hemolytic toxins, phosphodiesterases, 
phospholipases, hyaluronidase, glucosaminogly-
cans, histamine, seratonin, tryptophan and cytokine 
releasers. The most potent toxin is neurotoxin, 
which is divided in two classes viz. short chain and 
long chain peptides. Toxin peptides of both these 
classes are heat stable with low molecular weight. 
These are responsible for cell impairment in nerves, 
muscles and the heart by altering ion channel 
permeability. Long chain polypeptide neurotoxins 
cause stabilization of voltage dependent Na+ 
channel in open position leading to continuous 
prolonged repetitive firing of somatic, sympathetic 
and parasympathetic neurons. These repetitive 
firings result in autonomic and neuromuscular over 
excitation preventing normal nerve impulse trans-
mission. Further, it results in excessive release of 
neurotransmitters such as acetylcholine, glutamate, 
aspartate, epinephrine and norepinephrine. 
 Short chain polypeptide scorpion toxins are 
K+ channel blockers. Binding of these toxin peptides 
is reversible but with different binding affinities. 
Stability of these neurotoxins is due to four-
disulfide bridges that fold neurotoxin into a very 
compact three-dimensional structure, thus making it 
resistant to variation in hydrogen ion concentration 
and temperature. However, reagent that can break 
disulfide bridges can inactivate this toxin by 
unfolding it. Antigenicity of these toxins depends on 
the length and number of exposed regions out of the 
three-dimensional structure. 
 Fat tailed scorpion, A. australis has many 
toxin peptides, which are selectively lethal to 
mammals. This selectivity of venom can hardly be 
explained by food choice. This suggests a possible 
selective pressure for venom production against 
mammalian predators. It also helps to acquire other 
vertebrate prey as well. Also, if food acquisition is 
the main selective pressure for venom against 
vertebrates, then there should be higher compo-
sition of vertebrate toxins in large species like                 
P. imperator. The hypothesis for deterrence is 
supported by composition of venom. Besides, other 
pathological and physiological effect, serotoxin, 
which is a constituent of scorpion venom, also 
causes pain similar to that caused by apamin of 
honey bee. In fact, immediate stimulation of pain is 
one of the most important properties of scorpion 
venom. Generally, toxin factors that initiate pain do 
not cause death. This certainly is the result of other 
components present in the cocktail of substances in 
venom. Now, it is a well-known fact that among all 
different scorpion toxins, neurotoxins are the most 
lethal peptides that cause high mortality in animals. 
Scorpions use their pincers to grasp their prey and 
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then arch their tail over their body to inject their 
venom into the prey, sometimes more than once. 
Scorpions regulate how much venom should be 
injected with each sting. The striated muscles in the 
sting regulates amount of venom ejected, which is 
usually 0.1-0.6 mg. If entire supply of venom is 
used, scorpion must require several days to regain 
venom supply. 
 Although poisonous scorpions are classified 
taxonomically into several genera, yet the mode of 
action of their venom is quite similar. Scorpion 
venoms contain neurotoxic peptides in low 
abundance with great diversity in their mode of 
action. These neurotoxin peptides are low in 
abundance in a complex mixture of venom having a 
majority of the biological effects towards the 
affected victim. Stings affect peripheral nervous 
system resulting in symptoms like intense pain at 
the site of sting, altered heart activity and 
paraesthesia [17].  
 In an experiment with labeled scorpion 
venom, amount of venom venom was found 28%         
in blood, 30% in muscle, 13% in bone, 12% in 
kidney and 11% in liver within five minutes after 
intravenous administration. Scorpion venom is 
excreted through renal and hepaticbiliary pathways. 
The maximum renal uptake of 32% at thirty minu-
tes drops to 22% at three hours suggesting that 
excretion of venom through kidney is slow [18]. 
Scorpion venom in the animal body has a half-life 
of 24 hour indicating a slow clearance with mean 
residence time of 33.7 hours in the body and 26 
hours in the peripheral compartments [19]. 
 
2. INSECTICIDAL PROPERTY OF SCORPION 
VENOM 
 
 Due to species-specific activity of scorpion 
toxins, efforts have been made to identify insect 
selective toxins that can be used to develop 
biopesticides as a safer alternative to replace 
chemical insecticides [20-22]. On the basis of mode 
of action, anti-insect scorpion toxins have been 
divided into three classes viz. (i) alpha toxins which 
are strictly selective for insects (ii) excitatory insect 
selective scorpion toxins, and (iii) depressant insect 
selective neurotoxins [23-25]. Anti-insect α-toxin 
peptides bind to voltage-dependent sodium channels 
with high affinity [26].  
 Excitatory toxin causes a repetitive firing of 
axon accompanied by a small depolarization [27]. 
On the other hand, depressant toxin produces an 
inhibition of excitability due to depolarization of 
axon. Depressant toxins cause a decrease in sodium 
peak current and induce a constant inward current at 
negative membrane potential [28]. These effects are 
similar to that of the beta toxins active against 
vertebrate systems [29]. Several insect selective 
toxins have been identified from scorpion venom           
of different geographical regions [16, 17, 30, 31].  
AalT, a single chain neuropeptide isolated from 
Androctonus australis, has been proved insectotoxin 
by causing fast excitatory paralysis by presynaptic 
effect on insects’s motor nerve resulting in a 
massive and uncoordinated stimulation of skeletal 
muscles. The neuronal repetitive activity is attri-
buted to an exclusive and specific perturbation of 
sodium conductance as a consequence of toxin 
binding to external loop of insect’s voltage depen-
dent Na+ channel and modification of its gating 
mechanism [32]. Three toxin peptides (AaHIT1, 
AaHIT2, and AaHIT3) have been isolated from 
Androctonus australis venom which act against 
insect and are used as potential insecticidal agents. 
AaHIT1 gene linked to a sendai virus has been 
transformed to mosquitoes by viral infections, 
which upon transformation express lethal toxins/ 
proteins and resulted in death of host [33]. The other 
two toxin peptides are also insect specific similar to 
AaHIT1 [39]. 
 An anti-insect toxin peptide Lqh alpha IT has 
been isolated from L. quinquestriatus venom which 
causes a unique mode of paralysis in blowfly larvae 
[35]. Like excitatory and depressant insect toxins, 
Lqh alpha IT is highly toxic to insects but it           
differs from these in two important characteristics:              
(a) Lqh alpha IT lacks a strict selectivity for insects, 
highly toxic to crustaceans and also low toxic to 
mice. (b) It does not displace an excitatory toxin 
AalT from its binding site in insect neuronal 
membrane, which confirms that the binding site for 
the Lqh alpha IT is different from those imparted by 
excitatory and depressant toxins. Bot XIV isolated 
from B. occitanus occitanus is also an insecticidal 
toxin peptide but it does not show toxicity against 
mammals. This toxin peptide is highly antigenic in 
mice with the resulting antibodies having significant 
effectiveness in neutralizing other more toxic 
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proteins. Another antiinsect toxin Lqh III isolated 
from L. quenquestriatus affects sodium current in 
cockroach giant axon and prolongs action potential 
[36]. From M. tamulus, a short toxin peptide has 
been characterized which shows toxic effects 
against Helicoverpa armigera [37]. Gawade [38] 
has reported anti-insect toxin peptides, C56,             
from Buthus that has been shown to induce          
Ca++ dependent spontaneous excitatory activity            
in Drosophila larvae. Anti-insect toxin peptides 
characterized can be used in constructing genes and 
their in vitro expression product can be used as a 
replacement for synthetic pesticides. Albert et al. 
have expressed a synthetic gene encoding insecti-
cidal neurotoxin of A. australis (AaIT) in NIH/3T3 
mouse fibroblast cells under transcriptional control 
of a murine retro-viral long terminal repeat. Toxin 
peptides secreted in culture medium has been found 
toxic against yellow fever mosquito larvae but with 
no toxic effect on mice [20]. Genes of scorpion anti-
insect toxin peptides mainly neurotoxin peptides 
have been used with recombinant baculovirus. 
These genes have been selected to avoid human and 
other non-target neurotoxicity as much as possible. 
In such aim of insect control, depressant toxin has 
been found more effective than excitatory toxin in 
recombinant baculovirus [39]. 
 From a strict agro-technical point of view, 
two main points should be considered regarding            
the involvement of toxin peptide genes in plant 
protection (i) these act as a factor for genetic 
engineering of insect infective baculoviruses 
resulting in potent and selective bioinsecticides, and 
(ii) these must show pharmacological flexibility as a 
device for insecticide resistance management [32]. 
Indian red scorpion M. tamulus, known for its 
severe toxicity [40, 41], received little attention in 
this regard and only few toxin peptides have been 
reported for their insecticidal properties [42], while 
no such toxin peptides active against insects have 
been characterized from Heterometrus species till 
now. 
 
3. ANTIMICROBIAL PROPERTY OF 
SCORPION VENOM 
 
 Since the discovery of antimicrobial peptides 
in invertebrates [43], more than hundreds of 
antimicrobial proteins have been characterized in 
both invertebrates [44] and vertebrates [45] with a 
wide phylogenic distribution including humans [46]. 
These have been reported in skin, epithelial cells 
and blood of vertebrates as well as in insect 
haemolymph and venomous secretions of bees, 
hornet, spider and scorpions [47-49]. These toxins 
are small basic peptides with variable length, 
structure and sequence. These antimicrobial pepti-
des appear to form channels or pores in cell 
membrane inducing cell permeation and break down 
of cellular physiology [50]. These antimicrobial 
peptides have broad-spectrum, nonspecific activity 
against a wide range of microorganisms including 
viruses, gram-negative and gram-positive bacteria, 
protozoa, yeast and fungi, and may also be 
hemolytic and cytotoxic to cancerous cells [51, 52]. 
Antimicrobial peptides from scorpion venom are 
short peptides consisting of 10 to 50 amino acid 
residues  with a net positive charge ranging from +2 
to +9 and the proportion of hydrophobic residues  
are equal or more than 30% of total amino acids 
residues [53]. The positive amino acid residues are 
separated by patches of hydrophobic amino acids 
[54]. These antimicrobial peptides are usually 
cationic, amphipathic, α-helical peptides of low 
molecular eight (2-5 kD). Some peptides, such as 
hadrurin, are highly potent against both Gram-
positive bacteria and Gram-negative bacteria 
without preference, while others show selective 
activity against either Gram-negative bacteria 
(parabutoporin) or Gram-positive bacteria (IsCT and 
BmKn2) [55, 56]. 
 The pore forming antibacterial peptides of 
scorpion venom can be divided into two groups, 
depending on their primary and secondary 
structures: (a) linear, alpha helical peptides without 
cysteine residues, and (b) cysteine rich peptides that 
form a beta sheet or beta sheet and alpha helical 
structures [57]. Besides acting by destabilizing 
membrane structure and changing ion permea-
bilities, pore forming peptides can influence cell 
functioning by interacting with intracellular signa-
ling molecules such as G-proteins [58]. Although 
many antimicrobial peptides have been described             
in insects [59], several antimicrobial peptides have 
been isolated and characterized from scorpions 
including several cysteine-containing peptides           
from haemolymph of scorpion L. quinquestriatus 
hebraeus [60] and A. australis [61].  
276 | Chaubey   Scorpion venom: pharmacological analysis and its applications 
European Journal of Biological Research 2017; 7 (4): 271-290 
 
 The earliest peptide toxin ever studied was 
androctonin isolated from A. australis venom [62]. 
Androtonin shows potent antibacterial activity 
against both Gram-positive and Gram-negative 
bacteria [62]. Moerman et al. have also reported 
antifungal activity of androtonin [63]. Powers and 
Hancock have reported the antibacterial activity of 
parbutoporin (from P. schlechteri) and opistoporins 
(from Opistophthalmus carinatus). These peptide 
toxins target G-proteins for membrane lytic activity 
[64]. VpAmp1.0 and VpAmp2.0 peptides isolated 
from Vaejovis punctatus inhibit growth of both 
Gram-positive (Staphylococcus aureus and Strepto-
coccus agalactiae) and Gram-negative (Escherichia 
coli and Pseudomonas aeruginosa) bacteria, yeasts 
(Candida albicans and Candida glabrata) and two 
strains of Mycobacterium tuberculosis [65]. Opisin 
peptide isolated from Opistophthalmus globrifrons 
is a cationic, amphipathic, and α-helical molecule 
with 19 amino acid residues without disulfide 
bridges. This peptide inhibits growth of the some 
Gram-positive bacteria [66]. Stigmurin isolated 
from Brazilian yellow scorpion Tityus stigmurus 
venom gland shows antibacterial and antifungal 
activity [67]. Ctriporin isolated from Chaerilus 
tricostatus shows a broad-spectrum of antimicro-
bial activity and is able to inhibit antibiotic resistant 
pathogens, Staphylococcus aureus strains [68]. 
Hp1404 isolated from Heterometrus petersii is an 
amphipathic α-helical peptide with inhibitory acti-
vity against gram-positive bacteria like Staphylo-
coccus aureus [69]. 
 Buthinin, a three disulfide bridged bacte-
ricidal and fungicidal peptide, androctonin, with two 
disulfide bridges from A. australis venom and 
scorpine, a 75 residue antimicrobial peptide from          
P. imperator venom have been characterized [61, 
70]. Alpha-helical proteins containing antimicrobial 
properties have been reported from Hadrurus azte-
cus venom [71] and P. schlechteri [72]. Pandinin 1 
and pandinin 2 with antimicrobial property have 
been isolated from P. impretor venom [9]. Most of 
these antimicrobial peptides share some common 
characteristics such as their low molecular mass, 
presence of multiple lysine and arginine residues 
and their amphipathic nature. Their site of action             
is cytoplasmic membrane where they destabilize                 
its lipid package and produce transient channels                     
and disturb ion permeability across the membrane 
[73, 74].  
 Heterometrus xanthopus venom contains 
antimicrobial peptides like hadrurin, scorpine, 
Pandinin 1 and Pandinin 2. These peptides are able 
to kill antibiotic-resistant strains of Bacillus subtilis 
ATCC 6633, Salmonella typhimurium ATCC 
14028, Pseudomonas aeruginosa ATCC 27853 and 
Enterococcus faecalis ATCC 14506. Two anti-
microbial peptides have been identified from the 
venom of North African scorpion, A. aeneas.          
These peptides show antimicrobial activity against 
the Gram-positive bacterium, S. aureus and the 
yeast, C. albicans, but do not affect Gram-negative 
bacterium, E. coli [75]. Scorpion Leiurus quinque-
striatus venom shows significant broad-spectrum 
antimicrobial activity against Escherichia coli, 
Acinetobacter baumannii, Klebsiella pneumoniae, 
Pseudomonas aeruginosa, Staphylococcus aureus, 
Enterococcus faecalis, Candida albicans and 
Candida glabrata [76]. Despite of their high mini-
mum inhibitory concentration in comparison to 
other antibiotics, their broad spectrum of activity 
and speed of action makes them good candidates for 
drug delivery and for a number of other possible 
applications in pharmacological research [52]. 
 
4. ANTICANCER PROPERTY OF SCORPION 
VENOM 
 
 Cancer is a major health problem all over the 
world [77]. Treatment of cancer involves different 
clinical approaches including surgery, chemo-
therapy, radiotherapy, gene therapy, hormone 
therapy and immunological therapy either alone or 
in combinations. All of these approaches have its 
own advantages and disadvantages and mainly 
depend on the type and stage of cancer. Recent 
advancement in cancer therapy includes synthesis of 
peptides and proteins through DNA technology and 
production of monoclonal antibodies specific for 
oncoproteins. After realizing the medicinal use of 
anticancer proteins and peptides, many proteins of 
animal origin have been isolated. De Carvalho et al. 
isolated and characterized lectins (polyvalent 
carbohydrate binding proteins of non-immune 
origin) from snake Bothropos jararacussu venom 
which serve as an interesting tool by inhibiting 
tumor cells of human breast and ovarian cancer 
[78]. Some other group of scientists reported 
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anticancer effect of other lectins and toxins from 
some other snake venoms also [79-81]. 
 Scorpion venom contains a number of 
polypeptides with diverse biological activities. It has 
been earlier reported that venom of some scorpions 
has high histopathological and necrotic effects in 
human and animals [82, 83]. However, for the first 
time, Omran has reported anticancer property of 
Leiurus quinquestriatus venom on human breast 
cancer cell lines [84]. According to Bruses et al. 
[85] some toxins bind to a specific receptor in the 
membrane before they can exert their action. 
Anticancer effects of scorpion venoms have been 
evaluated in various types of cancers as glioma, 
neuroblastoma, leukemia, lymphoma, breast, lung, 
prostate and pancreatic cancer. These venoms 
produce anticancer effects by blocking specific ion 
channels, inhibiting invasion and metastasis of 
cancer cells and activating intracellular pathways 
leading to cell cycle arrest and apoptosis [86-88]. 
Venoms from various scorpions have been reported 
to prevent propagation of different cell lines such as 
prostate cancer, human leukemia and neuroblastoma 
[89-91]. Venom of A. crassicauda inhibited prolife-
ration of human neuroblastoma cell lines through 
arresting S-phase and induction of apoptosis [92].  
Almaaytah et al. characterized the cytolytic peptides 
AamAP1 and AamAP2 from the venom of North 
African scorpion A. amoreuxi [93]. They reported 
that the natural peptides AamAP1 and AamAP2 
show moderate antiproliferative activity against 
LNCaP, U251, PC3 and HMEC-1 cell lines.  The 
venom peptide Acra3 from A. crassicauda induces 
cytotoxic effect on mouse brain tumor cells 
(BC3H1) through both necrotic and apoptotic 
pathways [90]. Venom from the Buthidae scorpions 
A. bicolor, A. crassicauda and L. quinquestriatus 
show strong anticancer activity on colorectal and 
breast cancer cell lines through decreasing cell 
motility and colony formation of cancer cells [89].  
 
5. ION CHANNEL BLOCKING PROPERTY 
OF SCORPION VENOM 
 
 Scorpion venom contains several small 
neurotoxic peptides, which selectively act on 
various types of ion channels. These toxin peptides 
have been extensively used as valuable biochemical 
and pharmacological tools to characterize and 
discriminate various ion channel types that differ in 
ionic selectivity, structure and function. These 
neurotoxins affect victim by interfering with ionic 
balance and ion channel activity in excitable cells. 
Binding of scorpion toxins to target ion channels is 
known to occur through multiple interactions [94]. 
Numerous amino acid residues that determine the 
binding property to target ion channels have been 
characterized [15]. In addition, α-scorpion toxins are 
known to inhibit or slow down the Na+ ion channel. 
Scorpion toxin peptides can be divided into four 
 groups on the basis of their target ion 
channels. The first class belongs to toxin peptides 
acting on the Na+ channel, which consist of 60-70 
amino acid residues and four intermolecular 
disulfide bonds. These long chain toxin peptides 
modulate activation or inactivation of Na+ channels 
[15]. These toxin peptides alter kinetics of Na+ 
channel opening and closing in excitable cells              
[95]. Scorpion toxins affecting voltage-gated Na+ 
channels have been divided into two groups α- and 
β-toxins on the basis of their electrophysiological 
effects and binding properties. Alpha-toxins bind in 
a voltage dependent manner and inhibit depola-
rization of action potential while beta-toxins bind in 
a voltage independent manner and modulate the 
activation phase of action potential [96]. Makatoxin 
1 and bukatoxin, members of α-scorpion toxin 
family isolated from B. martensi venom show 
pharmacological action similar to other α-toxins on 
neuronal voltage sensitive sodium channels [97]. 
The toxin peptides from Buthidae family prolong 
Na+ ion activation phase of action potential while 
toxins from Centrurinae and Tityinae venom affect 
Na+ activation phase [98]. Ts-gamma, a neurotoxin 
of T. serrulatus produces very complex cardio-
logical effects characterized by an initial reduction 
of both rate and contractile force followed by an 
increase in force and reduction of rate. This 
contraction finally reduces due to release of 
acetylcholine from vagal endings [99]. This toxin 
apparently produces these effects on cell currents 
primarily by retarding activation of cardiac sodium 
channels [100]. Gawade et al. [38] have isolated and 
characterized a toxin peptide Lqh1β1 from Leiurus 
quinquestriatus hebraeus venom. It competes with 
anti-insect and anti-mammalian α-toxins for its 
binding site on Na+ channel. It also competes with 
an anti-mammalian α-toxin for its binding site. 
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 The second class of toxins includes K+ ion 
channel blockers. These toxin peptides consist of 
23-40 amino acid residues having three to four 
disulfide bonds. Bmpo2, a 28 amino acid residues 
peptide from B. mortensi venom shows very low 
inhibition of apamine sensitive Ca++-activated K+ 
channel [101]. Neurotoxic peptides tamulotoxin 
(TmTx) and iberiotoxin (IbTx) from M. tamulus 
having 37 amino acid residues and three disulfide 
bridges have shown to cause Ca++-activated K+ 
channel blockage  [102]. Other scorpion toxins with 
shorter polypeptide chain having less than 40 amino 
acid residues such as charybdotoxin and kaliotoxin 
also act on this channel [31, 103, 104]. Although 
numerous known scorpion toxins differ in size, 
sequence and biological activity, they all share a 
common structural motif consisting of antiparallel 
sheet linked to an amphipathic helix and an 
extended N-terminal fragment by three disulfide 
bridges [30]. This motif is also present in insect 
defensins, a family of inducible antibacterial 
peptides isolated from a variety of insects where 
they present a key element of the innate host 
defense against microorganisms [105]. 
 Romi-Lebrun et al. have isolated four 
peptideyl inhibitors of small conductance Ca++-
activated K+ channels from B. martensi [101]. C. 
noxius contains β-toxin which blocks voltage gated 
K+ channels by binding to site different than that                   
of other beta toxins [106]. Margatoxin of                          
C. margaritatus is a potent K+ channel blocker 
selecting for only one sub-type of K+ channel. This 
particular K+ channel is directly involved in 
lymphocytes activation and blocks lymphocyte 
activation and production of interleukin-2 by human 
T-lymphocytes [107-109]. Agitoxin of Leirus 
venom binds to external pore entry pathway of 
shaker K+ channel as well as mammalian 
homologues [110]. This toxin is related K+ channel 
neurotoxins but forms a new subclass of scorpion 
derived K+ channel inhibitors [100]. Scyllatoxin 
(laiurotoxin1) Leiurus binds to high conductance 
Ca++-activated K+ channels [111]. P. imperator 
venom contains peptides that binds and blocks 
voltage-gated K+ channels [112, 113]. Two toxin 
peptides viz. Imperatoxin A and Pil have been 
identified from P. imperator venom. Imperatoxin            
A selectively activates skeletal-type ryanodine 
receptor [114] and may prove a useful tool to 
identify regulatory domains critical for channel 
gating and to dissect the contribution of skeletal-
type Ca++ release channel/ryanodine receptor to 
intracellular Ca++ wave forms generated by stimu-
lation of different ryanodine receptor isoforms 
[115]. Pil toxin peptide selectively blocks shaker K+ 
ion channels [116]. Many researchers have isolated 
short chain polypeptides like Ibtx from B. tamulus 
[117], Titustoxin V from T. serrulatus [118], Osk-1 
from Orthochirus scrobiculosus [119] and Chtx 
from B. martensi [101]. These toxin peptides are 
potent inhibitors of voltage-gated K+ channels. 
Dhawan et al. (2003) have isolated a short toxin 
peptide BTK-2 from Buthus tamulus that inhibits K+ 
channel [37]. More et al. have reported a toxin 
peptide (PGT) fron Palamneus gravimanus. This 
toxin peptide selectively blocks the human cloned 
voltage-gated K+ channel [120]. 
 The third class of scorpion toxins acting on 
Cl- channels has 35-37 amino acid residues with  
four disulfide bonds [121]. Chlorotoxin from                 
L. quinquestriatus shows highest homology with 
short insect toxin [122]. The forth class includes 
toxins acting on Ca++ channels. These are short 
peptides with 25-35 amino acid residues [123, 124]. 
Kurtatoxin isolated from P. transvaalicus venom 
has been reported to inhibit voltage gated Ca++ 
channel [125]. 
Less than 1% of the estimated 0.1 million 
distinct peptides expected to exist in scorpion 
venom are known. It can be speculated that natural 
selection co-evolved distinct types and subtypes of 
receptors of ion channels in various groups of 
animals. At the same time scorpion evolved specific 
toxins designed to interfere with normal function of 
ion channels and to provide one way for scorpions 
to capture their prey or defend themselves from 
predators. 
 
6. CARDIOTOXIC PROPERTY OF SCORPION 
VENOM  
 
 Scorpion venom induces complex cardiac 
disorders in several animal species [126-128]. When 
isolated hearts have given short exposure of purified 
or crude venom toxins, cardiac muscles show 
considerable increase in contractility [99, 129, 130]. 
These complex cardiovascular effects by scorpion 
venom may probably due to direct effect on             
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vagal and sympathoadrenal stimulation [131-133]. 
Isolated myocytes show a higher rate of contraction 
and loss of synchronous activity under the influence 
of L. quinquestriatus venom [133]. Increased 
deoxyglucose and Ca++ uptake into cardiac cells and 
influx of Ca++ into sarcoplasmic changes prevented 
by pretreatment with propranolol and nifedipine 
accompany these changes. Further, this stimulation 
of adrenoreceptors leads to increased influx of                   
Ca++ through Ca++ channels which then increases 
contractility [133]. 
 Venoms of all scorpion species affect 
cardiovascular system and cause pulmonary oedema 
and cardiac arrhythmias [124]. Venoms also cause 
cholinergic as well as adrenergic neuron hyper-
stimulation by its acting on presynaptic membranes 
[125, 126]. These venoms have direct effect on 
gating mechanisms of excitable membranes [134]. 
As a result there is a massive release of 
catecholamines from synaptic nerve endings and 
from adrenal medulla [131, 137]. Elevations of 
circulating catecholamines and angiotensin result in 
intense vasoconstriction and cardiac stimulation 
[138], increased myocardial oxygen requirement 
and alteration in myocardial perfusions [134, 139]. 
Several of these mechanisms, together with a 
possible direct effect of toxin on myocardium may 
be responsible for myocarditis and focal myocardial 
necrosis in patients dying from envenomation [140]. 
Echocardiographic studies have shown severe 
systolic left ventricular dysfunction following 
envenomation [141, 142]. This is due to catechol-
amine induced metabolic abnormalities in 
myocardium (138), increased myocardial oxygen 
requirements [143], myocardial ischemia [139] and 
direct effect of toxin [130, 140]. Scorpion venoms 
containing bradykinin-potentiating peptides (hypo-
tensive agent) have been found in L. quinque-
striatus, T. serrulatus, B. martensii and B. occi-
tanus. These peptides act as bradykinin-potentiating 
peptides and can be used as hypotensive agents in 
the treatment of hypertension.  Moraes et al. have 
reprted that Tityus bahiensis scorpion venom modify 
sodium channel gating to exert hypotension action 
[144].    
 The scorpion venom exerts its lethal action  
by interference with blood coagulation, either by 
accelerating the process or inhibits the coagulation 
processes. A peptide with anti-thrombotic action  
has been reported from B. martensii venom [142]. 
This peptide is related to the resistance against 
platelet aggregation and increases concentration of 
prostanglandin I2 in plasma [142]. T. discrepans 
scorpion venom modifies clotting times in humans. 
T. discrepans venom also affects partial thrombo-
plastin time, prothrombin time and its direct clotting 
activity. This venom contains anticoagulant compo-
nents which prolong prothrombin time and partial 
thromboplastic time [143].  
 
7. OTHER PHARMACOLOGICAL ACTIVITIES 
OF SCORPION VENOM 
 
 Scorpion venom is known to modulate kinin 
pathway in animals. Kinins are peptides generated 
as a result of the activity of killikrekins (a group of 
proteolytic enzymes present in most of the tissues 
and body fluids) on kinogens. Once released, kinins 
such as bradykinin and related peptides kallikrekin 
(Lysbradykinin) and Met-Lys-bradykinin produce 
many physiological responses including pain and 
hyperanalgesia, in addition to contributing to 
inflammartory response [144, 145] M. tamulus 
venom causes increased peripheral sympathetic 
activity with consequent enhancement of adrenergic 
responses [146]. This venom also causes rhythmic 
fluctuation in blood pressure producing cardio-
vascular collapse and death. It induces spontaneous 
action potential and causes prolongation of action 
potential duration in purkinje fibres. This venom 
enhanced release of acetylcholine and induced 
repetitive firing of nerve action potentials [147]. 
This effect may be due to toxins that affect opening 
of Na+ channels in nerve and muscles, which results 
in increased release of neurotransmitters in 
peripheral nervous system. It may produce 
cardiovascular abnormalities and respiratory 
paralysis also. 
 Venom of B. tamulus causes severe 
pancreatitis [148], increased osmotic fragility in            
red blood cells [149, 150], myocarditis [151], 
hyperglycemia and lipolysis resulting in increased 
free fatty acids and reduction in triglyceride level 
[152]. All these cardiovascular, hemodynamic and 
hematological alternations may be due to massive 
release of catecholamines, counter-regulatory 
hormones like glucagons and cortisol [153], 
angiotensin II [138], thyroxine and triodothyronine 
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[154] and a reduced insulin secretion [155].                     
B. tumulus venom is found to be protease inhibitors 
and histamine releasers [40]. Effect of M. tamulus 
and L. quinquestriatus venoms on noradrenergic and 
nitinergic transmission in rat isolated anococcygeus 
muscle has revealed that both venoms mediate their 
pharmacological effects via prejunctional mecha-
nism involving activation of voltage sensitive Na+ 
channels with consequent release of neurotrans-
mitters mediated by other alpha scorpion toxin 
[156]. 
 Radha Krishna Murthy and Zare have 
reported an increase in hemoglobin, mean 
corpuscular hemoglobin concentration, packed cell 
volume, plasma hemoglobin levels and increased 
osmotic fragility of erythrocytes during scorpion 
envenomation [157]. Fragility of red blood cells has 
also been observed when incubated with scorpion 
venom. Rise in packed cell volume and mean 
corpuscular hemoglobin concentration during scor-
pion envenomation may be due to hemoconcen-
tration caused by a massive release of catechol-
amines [158-160] and angitensin II [138]. Phospho-
lipase present in venom could be the agent 
responsible for increased hemolysis. 
 Certain venoms such as cobra venom contain 
phospholipase A, which converts lecithin to 
lysolecithin, a powerful hemolytic substance [161]. 
Chhatwal and Habermann have reported presence     
of phospholipoase A2 in scropion venom [40].                
This enzyme is a powerful hemolytic agent and 
contributes to increased osmotic frgility of red   
blood cells [154]. Envenomation results in meta-
bolic stress in red blood cells and pumping 
mechanism failure [140]. A reduction in erythrocyte 
Na+K+ ATPase has been reported in scorpion     
sting victim [150]. Pande and Mead have observed 
inhibition of Na+K+ATPase activity by elevated  
free fatty acids through their detergent properties 
[162]. Hemiscorpius lepturus venom increases 
circulating levels of aspartae aminotransferase, 
alanine aminotrans-ferase, alkaline phosphatase, 
creatine phosphokinase and lactic dehydrogenase    
in rat [163]. Similarly, Omran and Abdel-Rahman 
have reported elevation in serum glucose, nitro-   
gen, creatine, glutamate oxaloacetate amino-
transferase, glutamate-pyruvate aminotransferase, 
creatine phosphokinase and lactic dehydrogenase, 
while reduction in serum total protein, uric acid, 
cholesterol, calcium and potassium [164]. 
 
8. SCORPION ANTIVENOM 
 
 Scorpion venom is a mixture of many small 
polypeptides known to induce a strong 
immunogenic reaction from the host. Potent 
neurotoxins, which often are relatively small and 
low abundance molecule, may not always induce 
production of sufficient quality and quantity of 
antibody molecules. Therefore, the balance between 
injected doses, toxicity towards subject animal 
should be maintained for high quality antibody 
production. Identification of less abundant but 
highly potent components in purified mixture and its 
use as an antigen is highly advantageous in 
comparison to crude venom to raise antibodies for 
therapeutic purposes. 
 Severity of scorpion venom and its rapid 
diffusion requires appropriate treatment, which must 
start as soon as possible after sting. Most 
investigators consider antivenom as the only 
specific treatment of scorpion stings [127, 165,]. 
However, others have questioned usefulness of 
antivenom in eliminating cardiovascular compli-
cations of scorpion stings [160, 166]. 
 Use of antivenom in the treatment of scorpion 
sting was started in 1909; and this mode of therapy, 
is still the only method used effectively against 
scorpion stings [167, 168]. Initially scorpion venom 
extracted from telson homogenate was used as 
antigen to inject in small doses in horses and sheeps 
to produce antivenom. After a long period of 
immunization, the blood of the immunized animal is 
obtained and the immunoglobulins are purified for 
use as antivenoms. Demagalhaes has claimed that 
toxicity of telson extract is less stable than that of 
pure venom [169]. Crude scorpion venom has many 
components, which shows poor antigenicity; 
therefore, other natural chemicals have been added 
to venom toxins to enhance antigenicity [170]. 
Scorpion venom is poor in antigenic composition 
and thus it is difficult to raise antibodies specific             
to neutralize lethal factor of scorpion venom. 
However, several attempts have been made to raise 
species-specific antibodies against scorpion venom. 
Mohammad et al.have used purified picrate venom 
obtained from dried telsons to prepare potent 
antivenom against Egyptean scorpion venom [171]. 
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At Hoffkin Biopharmacutical Corporation Ltd. 
Mumbai, Kapadia et al. have attempted to prepare 
anti-scorpion venom serum using grounded telson 
extract with Freund’s incomplete adjuvant [172]. 
The resulting antiserum, which contains antibo-   
dies against scorpion venom, has found to be 
inefficacious. Kankonkar et al. at Hoffkin Biophar-
maceutical Corporation Ltd. Mumbai, India have 
used Bentonite as adjuvant for extending period of 
immunization and prepared potent antiserum against 
Buthus tamulus venom capable of neutralizing lethal 
factors of venom [173]. 
 There are contradictory opinions about 
effectiveness of scorpion antivenom either in 
experimental animals or in scorpion sting victims. 
For quick neutralization of toxic effects of toxins, 
serotherapy is a well-tested pharmaceutical method 
that is used for safety of lives of many patients 
around the world [127, 158, 159, 174, 175]. 
Contrary to this, Gueron and his co-worker have 
reported that serotherapy is ineffective [160, 176]. 
Scorpions usually inject venom into interstitial 
spaces and not directly into blood circulation. 
Freire-Maia and Campos have suggested intra-
venous injection of antivenom to neutralize 
circulating venom [158]. Moreover, it is likely that 
antivenom administered intravenously can act on 
tissues later on. The best result can be achieved 
when antivenon is administered as early as possible 
and with adequate quantities to neutralize venom. 
Radha Kishana Murthy and Zare have reported              
that species-specific scorpion antiserum prepared              
at the Hoffkin Biopharmaceutical Corporation                 
Ltd. Mumbai, India, reverses metabolic and 
hematological alterations caused by Mesobuthus 
tamulus scorpion venom [154]. 
 Due to poor immunogenicity and vast 
difference in amino acid sequences in active site 
region, it is very tedious to prepare universal 
antivenon against scorpion venom. Furthermore, 
neurotoxic components of scorpion venom are          
least immunogenic. A recent idea for creating an 
universal anti-scorpion antivenom is to mix a batch 
of different anti-scorpion antivenin together to 
create a universal antivenin but this exposes patients 
to unnecessary antivenom from other scorpion 
species which are not from patient’s region.  
 Current method for anti-scorpion antivenom 
production involves direct injection of crude venom 
into horses. Besides it, antibodies are also produced 
from a mixture of a number of scorpion species 
venoms. However, there are risks associated with 
injection of antibodies from other animals or passive 
immunization. The recipient can mount a strong 
immunologic response to isotype determinants to 
foreign antibodies. This anti-isotype response can 
have serious complications because some recipients 
will produce IgE antibody specific for injected 
passive antibody. Immune complexes of IgE bound 
to antibody can mediate systemic mast cell 
degranulation leading to systemic anaphylaxis. 
Another possibility is that the recipient will produce 
IgG or IgM antibodies specific for foreign antibody, 
which will form complement activating immune 
complexes. The deposition of these complexes in 
tissues can lead to type III hypersensitive reaction. 
Another approach in neutralization of toxic effects 
of scorpion stings by serotherapy is possibility of 
raising antibodies to conserved parts of venom 
proteins, which could recognize several members of 
family. Devaux et al. have raised antibodies against 
an eight residue synthetic polypeptide, which 
represent conserved region in a set of 25 scorpion 
toxin sequences [177]. These peptide antibodies 
have been shown to cross-react with several 
scorpion toxins belonging to different serotype and 
neutralize pharmacological effects and biological 
activities. 
 Some special antivenoms are also available, 
which are the same horse antibodies treated with 
enzymes to produce F(ab)’2 fragments that are               
used for immunotherapy [178]. Recently smaller 
recombinant fragments, such as classic monovalent 
antibody fragments (FAB, scFv and engineered 
variants: diabodies, triabodies, minibodies and 
single-domain antibodies) are now engineering as 
credible alternatives. These fragments retain the 
targeting specificity of whole antibody and can be 
used for therapeutic applications [179]. Single-chain 
Fvs are popular format in which the VH and VL 
domains are joined with a flexible polypeptide 
linker preventing dissociation. Antibody Fab and 
scFv fragments, comprising both VH and VL 
domains,  usually retain the specific, monovalent, 
antigen binding affinity of the parent IgG, while 
showing improved pharmacokinetics for tissue 
penetration [179]. In this context, recently single 
chain antibodies of human origin have developed 
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and shown to be effective for neutralization of 




 Envenomation of humans by scorpion stings 
is a serious health problem in some parts of                   
the world. These venoms cause severe systemic 
inflammation and other complication when injected 
into humans. Scorpion venoms are mixture of 
peptides, amines, enzymes and many other bioactive 
compounds. The most important components, 
responsible for severe intoxication are short- and 
long-chain peptides affecting different ion channels 
(Na+, K+, Ca++, Cl-) either by blocking the channels 
or modifying their gating properties. They cause 
abnormal depolarization of the neuronal cells and if 
not treated on time can lead to death. Fot the 
neutralization of the venom’s induced deleterious 
effects, venom itself is used for production of 
antivenom in experimental animals like horse and 
sheep. Scorpion venoms possess some peptides 
having antimicrobial, anticancer and insecticidal 
properties. These make scorpion venom make it an 
important pharmacological agent in future for 
developing antimicrobial and antitumour drugs as 
well as insecticides on commercial scale. Some 
scorpion venom components have important 
applications for the treatment of different diseases 
like autoimmune, cardiovascular and inflammatory 
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